Better Therapeutics, Inc. (BTTX) Deferred Income Tax Expense (Benefit) USD 2020 - 2022

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Better Therapeutics, Inc. annual/quarterly Deferred Income Tax Expense (Benefit) history and growth rate from 2020 to 2022.
  • Better Therapeutics, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2021 was -$152 K.
  • Better Therapeutics, Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was $0.000.
  • Better Therapeutics, Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was -$152 K, a 200% decline from 2020.
Deferred Income Tax Expense (Benefit), Annual Data (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $0 +$152 K Jan 1, 2022 Dec 31, 2022 10-K 2023-03-30
2021 -$152 K -$304 K -200% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $152 K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.